Frontiers in Immunology | Vaccines and Molecular Therapeutics

Editorial

Published on 08 Feb 2023

Editorial: Innate immune responses to SARS-CoV-2 in infected and vaccinated individuals

in Vaccines and Molecular Therapeutics

Nitin K. Saksena
Pedro A. Reche
Srinivasa Reddy Bonam
Nicasio Mancini

Frontiers in Immunology

doi 10.3389/fimmu.2023.1141405

1,857 views
1 citation

Original Research

Published on 08 Feb 2023

Recombinant Pichinde viral vector expressing tuberculosis antigens elicits strong T cell responses and protection in mice

in Vaccines and Molecular Therapeutics

Natalie M. Kirk
Qinfeng Huang
Sophia Vrba
Mizanur Rahman
Alisha M. Block
Hannah Murphy
Dylan W. White
Sarah B. Namugenyi
Hinh Ly
Anna D. Tischler

Frontiers in Immunology

doi 10.3389/fimmu.2023.1127515

3,248 views
9 citations

Correction

Published on 08 Feb 2023

Corrigendum: Bioinformatics analysis and consistency verification of a novel tuberculosis vaccine candidate HP13138PB

in Vaccines and Molecular Therapeutics

Peng Cheng
Fan Jiang
Guiyuan Wang
Jie Wang
Yong Xue
Liang Wang
Wenping Gong

Frontiers in Immunology

doi 10.3389/fimmu.2023.1154693

1,220 views

Original Research

Published on 07 Feb 2023

Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders

in Vaccines and Molecular Therapeutics

Ryousuke Kasai
Michinori Funato
Kanako Maruta
Kunihiko Yasuda
Hiroshi Minatsu
Junji Ito
Kazuhiro Takahashi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1103196

2,042 views
1 citation

Correction

Published on 07 Feb 2023

Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes

in Vaccines and Molecular Therapeutics

Vidthiya Jeyanathan
Sam Afkhami
Michael R. D’Agostino
Anna Zganiacz
Xueya Feng
Matthew S. Miller
Mangalakumari Jeyanathan
Michael R. Thompson
Zhou Xing

Frontiers in Immunology

doi 10.3389/fimmu.2023.1151809

1,164 views
1 citation

Original Research

Published on 07 Feb 2023

Zika virus induced microcephaly and aberrant hematopoietic cell differentiation modeled in novel neonatal humanized mice

in Vaccines and Molecular Therapeutics

Kimberly Schmitt
James Z. Curlin
Leila Remling-Mulder
Tawfik Aboellail
Ramesh Akkina

Frontiers in Immunology

doi 10.3389/fimmu.2023.1060959

3,942 views
5 citations

Original Research

Published on 06 Feb 2023

A semi high-throughput whole blood-based flow cytometry assay to detect and monitor Bordetella pertussis-specific Th1, Th2 and Th17 responses

in Vaccines and Molecular Therapeutics

Véronique Corbière
Eleonora E. Lambert
Marine Rodesch
Jacqueline A. M. van Gaans-van den Brink
Alicja Misiak
Elles Simonetti
Anne Van Praet
Audrey Godefroid
Dimitri A. Diavatopoulos
Cécile A. C. M. van Els

Frontiers in Immunology

doi 10.3389/fimmu.2023.1101366

3,886 views
4 citations

Original Research

Published on 03 Feb 2023

Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting

in Vaccines and Molecular Therapeutics

James H. A. Clubb
Tatiana V. Kudling
Mykhailo Girych
Lyna Haybout
Santeri Pakola
Firas Hamdan
Víctor Cervera-Carrascon
Annabrita Hemmes
Susanna Grönberg-Vähä-Koskela
João Manuel Santos

Frontiers in Immunology

doi 10.3389/fimmu.2023.1060540

17,885 views
7 citations

Mini Review

Published on 03 Feb 2023

Precision-engineering of subunit vaccine particles for prevention of infectious diseases

in Vaccines and Molecular Therapeutics

Shuxiong Chen
Saranya Pounraj
Nivethika Sivakumaran
Anjali Kakkanat
Gayathri Sam
Md. Tanvir Kabir
Bernd H. A. Rehm

Frontiers in Immunology

doi 10.3389/fimmu.2023.1131057

8,080 views
17 citations

Original Research

Published on 02 Feb 2023

Design of a multi-epitope vaccine against six Nocardia species based on reverse vaccinology combined with immunoinformatics

in Vaccines and Molecular Therapeutics

Fei Zhu
Caixia Tan
Chunhui Li
Shiyang Ma
Haicheng Wen
Hang Yang
Mingjun Rao
Peipei Zhang
Wenzhong Peng
Yanhui Cui

Frontiers in Immunology

doi 10.3389/fimmu.2023.1100188

10,842 views
24 citations

Original Research

Published on 02 Feb 2023

Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot study

in Vaccines and Molecular Therapeutics

Sarra Mestiri
Maysaloun Merhi
Varghese P. Inchakalody
Nassiba Taib
Maria K. Smatti
Fareed Ahmad
Afsheen Raza
Fatma H. Ali
Shereena Hydrose
Queenie Fernandes

Frontiers in Immunology

doi 10.3389/fimmu.2023.1061255

4,235 views
3 citations

Original Research

Published on 02 Feb 2023

Global trends of Vaccinia oncolytic virus therapy over the past two decades: Bibliometric and visual analysis

in Vaccines and Molecular Therapeutics

Liu Bo
Liu Tianming
Fan Fengliang
Liang Wenping
Han Jinzuo
Xue Dongbo
Ma Biao
Sun Haijun

Frontiers in Immunology

doi 10.3389/fimmu.2023.1063548

3,323 views
1 citation

Original Research

Published on 02 Feb 2023

Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients

in Vaccines and Molecular Therapeutics

Isabel Pérez-Flores
Ignacio Juarez
Arianne S. Aiffil Meneses
Ana Lopez-Gomez
Natividad Calvo Romero
Beatriz Rodriguez-Cubillo
María Angeles Moreno de la Higuera
Belen Peix-Jiménez
Raquel Gonzalez-Garcia
Elvira Baos-Muñoz

Frontiers in Immunology

doi 10.3389/fimmu.2023.1111569

3,798 views
6 citations

Brief Research Report

Published on 31 Jan 2023

SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus

in Vaccines and Molecular Therapeutics

Almohanad A. Alkayyal
Reham Ajina
Marco Cacciabue
Aaesha A. Alkayyal
Nizar H. Saeedi
Taofik Hussain Alshehry
Feras Kaboha
Mohammed A. Alotaibi
Nada Zaidan
Khalid Shah

Frontiers in Immunology

doi 10.3389/fimmu.2023.1082191

4,867 views
1 citation

Original Research

Published on 31 Jan 2023

A novel, non-neuronal acetylcholinesterase of schistosome parasites is essential for definitive host infection

in Vaccines and Molecular Therapeutics

Patrick J. Skelly
Akram A. Da’dara

Frontiers in Immunology

doi 10.3389/fimmu.2023.1056469

3,028 views
9 citations

Review

Published on 31 Jan 2023

Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19

in Vaccines and Molecular Therapeutics

Jingli Du
Yue Su
Ruilan Wang
Enjun Dong
Yan Cao
Wenjuan Zhao
Wenping Gong

Frontiers in Immunology

doi 10.3389/fimmu.2023.1118378

8,992 views
7 citations